These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

527 related articles for article (PubMed ID: 22900881)

  • 1. Should pulp chamber pulpotomy be seen as a permanent treatment? Some preliminary thoughts.
    Simon S; Perard M; Zanini M; Smith AJ; Charpentier E; Djole SX; Lumley PJ
    Int Endod J; 2013 Jan; 46(1):79-87. PubMed ID: 22900881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MTA pulpotomy as an alternative to root canal treatment in children's permanent teeth in a dental public health setting.
    Alqaderi HE; Al-Mutawa SA; Qudeimat MA
    J Dent; 2014 Nov; 42(11):1390-5. PubMed ID: 24973732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized controlled trial of various MTA materials for partial pulpotomy in permanent teeth.
    Kang CM; Sun Y; Song JS; Pang NS; Roh BD; Lee CY; Shin Y
    J Dent; 2017 May; 60():8-13. PubMed ID: 27472957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pulpotomy in caries-exposed immature permanent molars using calcium-enriched mixture cement or mineral trioxide aggregate: a randomized clinical trial.
    Nosrat A; Seifi A; Asgary S
    Int J Paediatr Dent; 2013 Jan; 23(1):56-63. PubMed ID: 22309243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment Outcomes of Mineral Trioxide Aggregate Pulpotomy in Vital Permanent Teeth with Carious Pulp Exposure: The Retrospective Study.
    Linsuwanont P; Wimonsutthikul K; Pothimoke U; Santiwong B
    J Endod; 2017 Feb; 43(2):225-230. PubMed ID: 28041685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histology of Irreversible pulpitis premolars treated with mineral trioxide aggregate pulpotomy.
    Chueh LH; Chiang CP
    Oper Dent; 2010; 35(3):370-4. PubMed ID: 20533639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [An 18 month evaluation of MM-MTA pulpotomy on primary decayed molars].
    Abou Chedid JC; Mchayleh N; Khalil I; Melki B; Hardan LS
    Odontostomatol Trop; 2015 Dec; 38(152):17-24. PubMed ID: 26939217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pulpotomy of human primary molars with MTA and Portland cement: a randomised controlled trial.
    Sakai VT; Moretti AB; Oliveira TM; Fornetti AP; Santos CF; Machado MA; Abdo RC
    Br Dent J; 2009 Aug; 207(3):E5; discussion 128-9. PubMed ID: 19629145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mineral trioxide aggregate vs. formocresol in pulpotomized primary molars: a preliminary report.
    Eidelman E; Holan G; Fuks AB
    Pediatr Dent; 2001; 23(1):15-8. PubMed ID: 11242724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human Pulp Responses to Partial Pulpotomy Treatment with TheraCal as Compared with Biodentine and ProRoot MTA: A Clinical Trial.
    Bakhtiar H; Nekoofar MH; Aminishakib P; Abedi F; Naghi Moosavi F; Esnaashari E; Azizi A; Esmailian S; Ellini MR; Mesgarzadeh V; Sezavar M; About I
    J Endod; 2017 Nov; 43(11):1786-1791. PubMed ID: 28822566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment outcomes of pulpotomy in primary molars using two endodontic biomaterials. A 2-year randomised clinical trial.
    Malekafzali B; Shekarchi F; Asgary S
    Eur J Paediatr Dent; 2011 Sep; 12(3):189-93. PubMed ID: 22077689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative evaluation of platelet-rich fibrin and mineral trioxide aggregate as pulpotomy agents in permanent teeth with incomplete root development: a randomized controlled trial.
    Keswani D; Pandey RK; Ansari A; Gupta S
    J Endod; 2014 May; 40(5):599-605. PubMed ID: 24767550
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mineral trioxide aggregate and formocresol pulpotomy of primary teeth: a 2-year follow-up.
    Ansari G; Ranjpour M
    Int Endod J; 2010 May; 43(5):413-8. PubMed ID: 20518934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and radiographic evaluation of vital pulp therapy in open apex teeth with MTA and ZOE.
    Ghoddusi J; Shahrami F; Alizadeh M; Kianoush K; Forghani M
    N Y State Dent J; 2012 Apr; 78(3):34-8. PubMed ID: 22803275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calcium hydroxide vs mineral trioxide aggregates for partial pulpotomy of permanent molars with deep caries.
    Qudeimat MA; Barrieshi-Nusair KM; Owais AI
    Eur Arch Paediatr Dent; 2007 Jun; 8(2):99-104. PubMed ID: 17555692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mineral trioxide aggregate versus calcium hydroxide for pulpotomy in primary molars.
    Liu H; Zhou Q; Qin M
    Chin J Dent Res; 2011; 14(2):121-5. PubMed ID: 22319753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of mineral trioxide aggregate and formocresol as pulp medicaments for pulpotomies in primary molars.
    Noorollahian H
    Br Dent J; 2008 Jun; 204(11):E20. PubMed ID: 18425074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and radiographic success rates of mineral trioxide aggregate and ferric sulphate pulpotomies performed by dental students.
    Odabaş ME; Alaçam A; Sillelioğlu H; Deveci C
    Eur J Paediatr Dent; 2012 Jun; 13(2):118-22. PubMed ID: 22762173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Short-term treatment outcome of pulpotomies in primary molars using mineral trioxide aggregate and Biodentine: a randomized clinical trial.
    Cuadros-Fernández C; Lorente Rodríguez AI; Sáez-Martínez S; García-Binimelis J; About I; Mercadé M
    Clin Oral Investig; 2016 Sep; 20(7):1639-45. PubMed ID: 26578117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and radiographic outcomes of pulpotomized primary molars treated with white or gray mineral trioxide aggregate and ferric sulfate--long-term follow-up.
    Frenkel G; Kaufman A; Ashkenazi M
    J Clin Pediatr Dent; 2012; 37(2):137-41. PubMed ID: 23534318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.